Drug Shortage Report for ADENOSINE INJECTION

Last updated on 2022-05-03 History
Report ID 159836
Drug Identification Number 02457482
Brand name ADENOSINE INJECTION
Common or Proper name ADENOSINE INJECTION
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ADENOSINE
Strength(s) 3MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 4ML
ATC code C01EB
ATC description OTHER CARDIAC PREPARATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-05-02
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-05-03
Company comments Effective May 2, 2022, this product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-05-03 English Compare
v2 2022-05-02 French Compare
v1 2022-05-02 English Compare

Showing 1 to 3 of 3